Trial intelligence / Profile preview

Phase II study of QP001 injection for postoperative abdominal surgery pain

ChiCTR2200055326Phase 2Recruiting

Sponsor
Third Xiangya Hospital, Central South University
Start
Oct 2021
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 2, randomised trial of QP001 in postoperative pain (3 arms), sponsored by Third Xiangya Hospital, Central South University. Primary endpoints: Numerical Score Pain Intensity Score and Subject satisfaction score. Started Oct 2021; status: recruiting.

02

Drugs

QP001
03

Conditions

postoperative pain

Beyond the preview

Go deeper on ChiCTR2200055326.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2200055326.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call